GG
AGN

Gofen & Glossberg’s Allergan plc AGN Stock Holding History

Gofen & Glossberg’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,872
Closed -$1.75M – 459
2020
Q1 		$1.75M Sell
9,872
-593
-6% -$112K 0.07% 158
2019
Q4 		$2M Sell
10,465
-2,685
-20% -$484K 0.06% 166
2019
Q3 		$2.21M Sell
13,150
-2,378
-15% -$387K 0.07% 157
2019
Q2 		$2.6M Sell
15,528
-2,144
-12% -$297K 0.09% 142
2019
Q1 		$2.59M Sell
17,672
-4,240
-19% -$615K 0.09% 142
2018
Q4 		$2.93M Sell
21,912
-21,611
-50% -$3.54M 0.12% 129
2018
Q3 		$8.29M Sell
43,523
-6,432
-13% -$1.18M 0.28% 89
2018
Q2 		$8.33M Sell
49,955
-10,951
-18% -$1.76M 0.31% 89
2018
Q1 		$10.3M Sell
60,906
-16,677
-21% -$2.8M 0.38% 78
2017
Q4 		$12.7M Sell
77,583
-10,181
-12% -$1.83M 0.45% 69
2017
Q3 		$18M Buy
87,764
+4,729
+6% +$1.1M 0.67% 46
2017
Q2 		$20.2M Buy
83,035
+10,159
+14% +$2.39M 0.77% 39
2017
Q1 		$17.4M Buy
72,876
+2,118
+3% +$493K 0.68% 44
2016
Q4 		$14.9M Sell
70,758
-10,194
-13% -$2.11M 0.61% 51
2016
Q3 		$18.6M Buy
80,952
+5,994
+8% +$1.46M 0.77% 37
2016
Q2 		$17.3M Buy
74,958
+25,269
+51% +$5.83M 0.72% 43
2016
Q1 		$13.3M Buy
49,689
+3,907
+9% +$1.12M 0.57% 58
2015
Q4 		$14.3M Buy
45,782
+1,723
+4% +$513K 0.62% 51
2015
Q3 		$12M Buy
44,059
+2,101
+5% +$645K 0.54% 58
2015
Q2 		$12.7M Buy
41,958
+2,097
+5% +$625K 0.54% 55
2015
Q1 		$11.9M Buy
+39,861
New +$11.4M 0.51% 63

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Gofen & Glossberg's AGN Position: Q2 2020 in Review

Gofen & Glossberg sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,872 shares — an estimated $1.75M sold.

Gofen & Glossberg first reported a position in AGN in Q1 2015 and held it in 21 quarters. The position peaked at $20.2M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Gofen & Glossberg reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Gofen & Glossberg sold 9,872 Allergan plc shares in Q2 2020, an estimated $1.75M.
  • Gofen & Glossberg first reported a position in Allergan plc in Q1 2015 and held it in 21 quarters.
  • Gofen & Glossberg's Allergan plc position peaked at $20.2M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Gofen & Glossberg's 13F filing for Q2 2020, filed 13 Jul 2020.